George Nakayama Chairman and CEO PLAY LIST from the beginning DS-8201 Strategic Collaboration Forward-Looking Statements DS-8201 Strategic Collaboration 1.Overview DS-8201 Strategic Collaboration Overview-1 DS-8201 Strategic Collaboration Overview-2 Financial Terms of DS-8201 Collaboration 2.Significance Significance of the Collaboration Accelerate DS-8201 Commercialization & Development Early Market Penetration through Collaboration Accelerate and Expand Development through Collaboration Building DS-8201 in Breast Cancer and Beyond Maximize the Product Value of DS-8201 Accelerate Establishment of DS Global Oncology Infrastructure Expand Resource Allocation for Other ADC Programs Summary DS-8201: Acceleration of BLA Submission in U.S. DS-8201: Acceleration of BLA Submission in U.S. Contact address regarding this material Q&A Q&A 1 Q&A 2 Q&A 3 Q&A 4 Q&A 5 Q&A 6 Q&A 7 Q&A 8 Q&A 9 Q&A 10 Q&A 11 Q&A 12 Q&A 13 Back Next